STOCK TITAN

CENTENE APPOINTS LAUREN M. TYLER TO BOARD OF DIRECTORS

(Neutral)
(Neutral)
Tags
management

Centene (NYSE:CNC) appointed Lauren M. Tyler to its Board of Directors, effective June 19, 2026. She will join the Audit Committee and Compensation and Talent Committee. Tyler brings over 30 years of leadership experience in investment banking, private equity, audit, investor relations, and human capital strategy.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – CNC

-0.85%
2 alerts
-0.85% Session close to close
$31.39B Market Cap
0.0x Rel. Volume

In the Jun 23 session, CNC declined 0.85%, reflecting a mild negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ST. LOUIS, June 22, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026. Ms. Tyler will serve on the Audit Committee and Compensation and Talent Committee.

Ms. Tyler brings more than 30 years of leadership experience across investment banking, private equity, corporate audit, investor relations, and human capital strategy.

"Lauren's longstanding track record guiding global, complex organizations through transformation while prioritizing governance, talent development, and operational rigor will be key as Centene continues to evolve and deliver on its mission," said CEO Sarah M. London.

Ms. Tyler spent over two decades at JPMorgan Chase & Co., where she held senior roles including Executive Vice President and Global Head of Human Resources for Asset and Wealth Management, Global Firmwide Chief Auditor, and Global Head of Investor Relations. Earlier in her career, she held roles at TSG Capital Partners, Allen & Company, and Morgan Stanley.

She currently serves on the boards of Cencora, Inc., and Guardian Life. She previously served on the board of Alleghany Corporation until its acquisition in 2022. Ms. Tyler holds an MBA from Harvard Business School and a BA from Yale University.

"Lauren's seasoned board experience and proven leadership guiding complex organizations through dynamic operating environments will make her a strong addition to our Board," said Chairman Frederick H. Eppinger.

"I am honored to join Centene's Board, a company whose mission I deeply admire, and look forward to working closely with the company's leadership to make an impact on improving the health of the communities it serves nationwide," said Ms. Tyler.

About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace. 

Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com/. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/centene-appoints-lauren-m-tyler-to-board-of-directors-302806827.html

SOURCE Centene Corporation

FAQ

What did Centene (NYSE:CNC) announce about its board on June 22, 2026?

Centene announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026. According to Centene, she will serve on the Audit Committee and the Compensation and Talent Committee, strengthening oversight of governance, financial reporting, and talent strategy.

Who is Lauren M. Tyler, newly appointed to the Centene (CNC) Board of Directors?

Lauren M. Tyler is a seasoned executive with more than 30 years of leadership experience. According to Centene, she held senior roles at JPMorgan Chase, including Global Firmwide Chief Auditor and Global Head of Investor Relations, and currently serves on the boards of Cencora and Guardian Life.

Which board committees will Lauren M. Tyler serve on at Centene (CNC)?

Lauren M. Tyler will serve on Centene’s Audit Committee and Compensation and Talent Committee. According to Centene, these assignments leverage her background in corporate audit, investor relations, and human capital strategy to support financial oversight, governance, executive pay, and talent development priorities.

When does Lauren M. Tyler’s appointment to the Centene (CNC) board become effective?

Lauren M. Tyler’s appointment to Centene’s Board of Directors became effective on June 19, 2026. According to Centene, the appointment was announced publicly on June 22, 2026, reflecting the company’s ongoing evolution of its board leadership and governance structure.

What prior experience does Lauren M. Tyler bring to the Centene (CNC) board?

Lauren M. Tyler brings extensive experience in human resources, audit, and investor relations from JPMorgan Chase. According to Centene, her background also includes roles at TSG Capital Partners, Allen & Company, Morgan Stanley, and board service at Cencora, Guardian Life, and previously Alleghany.

How might Lauren M. Tyler’s background support Centene’s (CNC) strategic direction?

Lauren M. Tyler’s experience guiding complex organizations through transformation may support Centene’s evolving strategy. According to Centene leadership, her focus on governance, talent development, and operational rigor aligns with the company’s mission to improve health outcomes in the communities it serves nationwide.